Targeted chimeric proteins and uses thereof
US11384154B2 · kind B2 · utility
1Cited by
20References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 5, 2018 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Mar 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to chimeric proteins comprising at least one targeting moiety that recognizes and binds SIRP1α and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the chimeric proteins and their use in the treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.